 |
|
|
|
|
|
|
| Article 1 to 10 out of 19 concerning Applera Corporation
|
-
Applied Biosystems, 454 Life Sciences and Illumina Join 1000 Genomes Project
(13 Jun 2008)
Biotech Innovators Will Contribute to International Effort To Produce Most Detailed Map of Genetic Variation
Leaders of the 1000 Genomes Project announced that three firms that have pioneered development of new sequencing technologies have joined the international effort to build the most detailed map to date of human genetic variation as a tool for ...
-
BIOTECON Diagnostics signs license agreement with Applera Corporation
(26 May 2008)
Applera and BIOTECON Diagnostics (BCD) announced a non-exclusive, worldwide license agreement relating to PCR technology for Food Testing Applications and Genetically-Modified Organism (GMO) Testing Applications: BIOTECON Diagnostics has acquired ...
-
Lab21 signs a license with Celera for one of the first diagnostic tests for cirrhosis risk in hepatitis C patients
(25 Feb 2008)
Lab21 announced that it has obtained a licence from Celera, an Applera Corporation business, to provide access to its test for cirrhosis risk in patients with chronic hepatitis C viral (HCV) infection in the UK and Ireland.The test, known as CRS7, ...
-
Enigma sign real-time PCR license with Applera
(11 Feb 2008)
Enigma Diagnostics announced that it has signed license agreements with Applera Corporation. The licenses, signed 6 February 2008, include a Real-Time Instrument Patent License Agreement and an Application Kit License Agreement. These agreements ...
-
Scientists in Spain Develop a Panel of Genetic Markers for Tracing Meat from Farm to Fork
(11 Dec 2007)
Researchers collaborate with Applied Biosystems to validate specific genetic polymorphisms for identifying individual pigs from commercial breeds
Scientists at the Universitat Autònoma de Barcelona, Spain, have developed and validated an identity test that can be used to confirm the breed and origin of meat from farm animals. The test was developed in collaboration with Applied Biosystems , ...
-
Scientists Discover New Molecular Markers for Testicular Cancer
(18 Oct 2007)
Researchers in the Netherlands use new technology from Applied Biosystems to identify different expression patterns of microRNA molecules in normal and cancerous cells
Scientists at the Erasmus MC-University Medical Center in Rotterdam, The Netherlands and Applied Biosystems, an Applera Corporation business, have made significant advances in testicular cancer research by identifying and analyzing a set of specific ...
-
Applied Biosystems/U.S. Department of Defense Terminate Contract for Prototype Instrument System to Identify Infectious Diseases
(06 Jun 2007)
Parties Could Not Agree on Further Development and Commercialization
Applied Biosystems, an Applera Corporation business, announced that its contract with the U.S. Department of Defense surrounding the development of a prototype instrument system to improve the way infectious diseases are identified for ...
-
Enzo named senior party in interference for patent of basic DNA gel sequencing
(21 Nov 2006)
Enzo Biochem, Inc. announced that the United States Patent and Trademark Office has declared a patent interference between an allowed patent application of its subsidiary, Enzo Life Sciences, Inc., and a patent held by California Institute of ...
-
Researchers Identify New Protein Biomarker Candidates That May Lead To Better Diagnosis And Treatment For Age-Related Diseases
(25 Aug 2006)
Alzheimer's Disease, Parkinson's Disease and Dementia with Lewy Bodies Targeted in Protein Study Enabled by Applied Biosystems/MDS SCIEX's Advanced Technologies
Applied Biosystems, an Applera Corporation business, and its joint venture partner, MDS Sciex, a division of MDS Inc., announced the outcome of the scientific research community's most extensive, spinal fluid-based protein study on neurodegenerative ...
-
Celera Genomics Receives NIH Grant to Develop and Commercialize Avian Flu Diagnostic Test
(24 Aug 2006)
Celera Genomics, an Applera Corporation business, announced that the National Institutes of Health (NIH) has awarded Celera approximately $900,000 to develop and commercialize an in vitro diagnostic (IVD) test for the highly pathogenic influenza ...
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon